HitGen to Discover Small Molecule Leads for India's Sun Pharma Unit
publication date: Mar 14, 2019
HitGen of Chengdu will collaborate with India's Sun Pharma Advanced Research Company to discover small molecule leads. HitGen will search its DNA-encoded library of leads, now numbering more than 400 billion novel, diverse, drug-like compounds. to discover lead molecules for SPARC. SPARC will make an upfront payment to HitGen and be responsible for additional milestone payments. HitGen has formed many discovery collaborations with the world's biopharmas, including most recently Biogen, Bayer and Genentech. More details....
Stock Symbol: (BSE: 532872)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.